CTMX
CytomX Therapeutics, Inc.stockNASDAQ
Market OpenNov 19, 2026 9:44:16 AM EST
1.90USD+1.064%(+0.02)223,711
Pre-marketNov 19, 2026 9:26:30 AM EST
1.9107USD+1.633%(+0.0307)
CTMX Financials
In Q3 FY 2026 (ended ), CytomX Therapeutics, Inc. (CTMX) reported revenue of $1.69M, net income of −$20M, operating cash flow of $16.65M, and assets of $364.68M (filed ).
Loading financial statements…
